Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Dexcom (DXCM) Receivables - Other (2018 - 2026)

Dexcom has reported Receivables - Other over the past 9 years, most recently at $16.9 million for Q1 2026.

  • Quarterly Receivables - Other rose 14.97% to $16.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $16.9 million through Mar 2026, up 14.97% year-over-year, with the annual reading at $16.9 million for FY2025, 11.18% up from the prior year.
  • Receivables - Other was $16.9 million for Q1 2026 at Dexcom, roughly flat from $16.9 million in the prior quarter.
  • Over five years, Receivables - Other peaked at $17.0 million in Q2 2025 and troughed at $8.0 million in Q4 2023.
  • The 5-year median for Receivables - Other is $10.3 million (2022), against an average of $12.3 million.
  • Year-over-year, Receivables - Other dropped 16.22% in 2022 and then soared 90.0% in 2024.
  • A 5-year view of Receivables - Other shows it stood at $9.0 million in 2022, then fell by 11.11% to $8.0 million in 2023, then soared by 90.0% to $15.2 million in 2024, then grew by 11.18% to $16.9 million in 2025, then changed by 0.0% to $16.9 million in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Receivables - Other are $16.9 million (Q1 2026), $16.9 million (Q4 2025), and $16.6 million (Q3 2025).